Home
About
FAQ
History (13)
ASO Author Reflections: Molecular Profiling Can Provide Personalized Clinical Guidance in the Management of Peritoneal Malignancies.
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Loss of autophagy causes a synthetic lethal deficiency in DNA repair.
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
EGFR and HER2 signaling in breast cancer brain metastasis.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EGFR and HER2 signaling in breast cancer brain metastasis.
Sirkisoon SR, Carpenter RL, Rimkus T, Miller L, Metheny-Barlow L, Lo HW. EGFR and HER2 signaling in breast cancer brain metastasis. Front Biosci (Elite Ed). 2016 Jan 01; 8:245-63.
View in:
PubMed
subject areas
Brain Neoplasms
Breast Neoplasms
Clinical Trials as Topic
Humans
Models, Biological
Receptor, erbB-2
Signal Transduction
authors with profiles
Linda J. Metheny-Barlow PhD
Lance D. Miller PhD, MS